EBAY
50
2
EOG
54
-2
COST
57
4
QCOM
55
2
CAH
54
-2
FDX
36
-3
GT
41
-2
CCI
25
-13
CHRW
62
3
NFLX
59
2
KR
40
-2
PFE
42
-3
GE
70
2
FOX
66
-4
BA
39
4
NTAP
61
2
PHM
54
-4
AMAT
59
4
EIX
34
3
AVGO
66
2
EBAY
50
2
EOG
54
-2
COST
57
4
QCOM
55
2
CAH
54
-2
FDX
36
-3
GT
41
-2
CCI
25
-13
CHRW
62
3
NFLX
59
2
KR
40
-2
PFE
42
-3
GE
70
2
FOX
66
-4
BA
39
4
NTAP
61
2
PHM
54
-4
AMAT
59
4
EIX
34
3
AVGO
66
2
Financhill
Back

PTC Therapeutics Stock Predictions

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]
Sell
20

PTCT
PTC Therapeutics

Last Price:
$43.92
Seasonality Move:
-9.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]

PTC Therapeutics Stock Forecast

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 18.8% based on the past 11 years of stock performance.
  • PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
  • Is PTC Therapeutics Stock Undervalued?
    The current PTC Therapeutics [PTCT] share price is $43.84. The Score for PTCT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 18.8% based on the past 11 years of stock performance.

PTC Therapeutics Stock Rating

Sell
20
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics overpriced?

  • PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com

52-Week Data

52-Week High:
54.16
52-Week Low:
23.58

Prediction Charts

Market Cap:
3.4B
Price in USD:
43.84
Volume:
941.3K
Beta:
0.84

Technical Analysis

SMA50:
45.07
SMA100:
40.91
SMA200:
36.72
52-Wk Change:
56.01%

Stock Predictions

  • Is PTC Therapeutics stock public?
    Yes, PTC Therapeutics is a publicly traded company.
  • What is the PTC Therapeutics stock quote today?
    The PTC Therapeutics stock price is 43.84 USD today.
  • How to buy PTC Therapeutics stock online?
    You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-27 45.34 45.23 46.11 44.70
Dec-30 44.70 45.77 45.95 44.58
Dec-31 45.86 45.14 46.79 44.71
Jan-2 46.17 45.88 47.06 45.47
Jan-3 45.96 46.54 46.73 45.83
Jan-6 46.08 45.78 46.71 45.73
Jan-7 45.85 44.61 47.00 44.37
Jan-8 43.99 45.04 45.27 43.50
Jan-10 43.68 43.94 45.59 43.63
Jan-13 43.50 44.05 44.92 42.35
Jan-14 43.67 41.81 44.69 41.67
Jan-15 42.92 42.27 44.32 41.87
Jan-16 42.00 43.08 43.16 41.75
Jan-17 43.31 43.84 44.55 42.18

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $1.12 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.